Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a […]

The post Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate first appeared on World Pharma Today.



This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here

Share the post

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

×

Subscribe to Leading Pharmaceutical Industry Online Platform

Get updates delivered right to your inbox!

Thank you for your subscription

×